.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
AstraZeneca
Federal Trade Commission
Colorcon
Accenture
US Army
Harvard Business School
Dow
Mallinckrodt

Generated: November 18, 2017

DrugPatentWatch Database Preview

Alcohol; chlorhexidine gluconate - Generic Drug Details

« Back to Dashboard

What are the generic sources for alcohol; chlorhexidine gluconate and what is the scope of alcohol; chlorhexidine gluconate patent protection?

Alcohol; chlorhexidine gluconate
is the generic ingredient in one branded drug marketed by 3M and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Alcohol; chlorhexidine gluconate has eleven patent family members in six countries.

There are forty drug master file entries for alcohol; chlorhexidine gluconate. One supplier is listed for this compound.

Summary for alcohol; chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001OTCYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alcohol; chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
3m
AVAGARD
alcohol; chlorhexidine gluconate
SOLUTION;TOPICAL021074-001Jun 7, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: alcohol; chlorhexidine gluconate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,090,395 Stable hydroalcoholic compositions► Subscribe
7,566,460Stable hydroalcoholic compositions► Subscribe
6,623,744 Stable hydroalcoholic compositions► Subscribe
6,534,069 Stable hydroalcoholic compositions► Subscribe
7,803,390Stable hydroalcoholic compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alcohol; chlorhexidine gluconate

Country Document Number Estimated Expiration
Australia715468► Subscribe
Canada2224702► Subscribe
European Patent Office0833606► Subscribe
European Patent Office1407761► Subscribe
Japan4497559► Subscribe
Germany69630221► Subscribe
Australia6103496► Subscribe
Japan2010001294► Subscribe
World Intellectual Property Organization (WIPO)9700668► Subscribe
JapanH11508253► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Healthtrust
Novartis
US Department of Justice
Queensland Health
McKesson
Dow
Harvard Business School
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot